2009
DOI: 10.1371/journal.pone.0004788
|View full text |Cite
|
Sign up to set email alerts
|

DNA Methylation of the ABO Promoter Underlies Loss of ABO Allelic Expression in a Significant Proportion of Leukemic Patients

Abstract: BackgroundLoss of A, B and H antigens from the red blood cells of patients with myeloid malignancies is a frequent occurrence. Previously, we have reported alterations in ABH antigens on the red blood cells of 55% of patients with myeloid malignancies.Methodology/Principal FindingsTo determine the underlying molecular mechanisms of this loss, we assessed ABO allelic expression in 21 patients with ABH antigen loss previously identified by flow cytometric analysis as well as an additional 7 patients detected wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

3
45
0
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 61 publications
(49 citation statements)
references
References 47 publications
3
45
0
1
Order By: Relevance
“…This is due to loss of heterozygosity, a promoter methylation, and increase of gene expression or neoexpression [65-67]. Hypoxic microenvironments change the expression of glycosyltransferase genes, such as fucosyltransferases (FUTs), N -acetylglucosaminyltransferases (GnTs), and sialyltransferases (STs) [68-70].…”
Section: Hypoxia Regulates Glycosyltransferases Glycosidases and Nucmentioning
confidence: 99%
“…This is due to loss of heterozygosity, a promoter methylation, and increase of gene expression or neoexpression [65-67]. Hypoxic microenvironments change the expression of glycosyltransferase genes, such as fucosyltransferases (FUTs), N -acetylglucosaminyltransferases (GnTs), and sialyltransferases (STs) [68-70].…”
Section: Hypoxia Regulates Glycosyltransferases Glycosidases and Nucmentioning
confidence: 99%
“…Le système de groupes sanguins ABO est le principal type des groupes sanguins classés en quatre phénotypes (A, B, O et AB) [4] [5] [6] [11] [12] selon la présence ou l'absence des antigène et anticorps spécifiques sur la membrane des hématies ou dans le plasma [7] [9] [10]. Ces antigènes (localisés sur le chromosome 9) sont de nature glucidique: D-galactose pour l'antigène B et N-acétylgalactosamine pour l'antigène A [1] [10] [13] [14]. Génétiquement le A et B sont des allèles Codominant et le O est récessif [13].…”
Section: Introductionunclassified
“…This process is significant during the development, differentiation, and maturation of normal cells [6]. ABH antigens are deleted or reduced in various cancers including myeloid malignancies [7], leukemia [8], oral cancer [9], and bladder cancer [10]. The A-transferase gene promoter region contains CpG-rich sites whose methylation status correlates well with gene expression; treatment with 5-aza-dC results in the appearance of A-transferase gene and A-antigen expression [11].…”
Section: Introductionmentioning
confidence: 99%
“…Loss of H antigen in myeloid malignancies and leukemia [7, 8] and loss of α 1,2-fucosyltransferase (FUT) activities in gastric cancer [15] are common, although the mechanism remains to be elucidated. FUT1 (H enzyme) and FUT2 (Se enzyme) genes are cloned and responsible for synthesis of α 1,2-fucosylation on both core structures of type 1/2, Gal β 1,3/4GlcNAc-R, producing H antigen and Lewis B/Y, Fuc α 1,2Gal β 1,3/4(Fuc α 1,4/3)GlcNAc-R [16, 17].…”
Section: Introductionmentioning
confidence: 99%